Welcome to LookChem.com Sign In|Join Free
  • or
1,11a-didehydroanhydroanthramycin is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

77165-77-6

Post Buying Request

77165-77-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

77165-77-6 Usage

Chemical compound

1,11a-didehydroanhydroanthramycin is a chemical compound that belongs to the anthramycin family of antibiotics.

Unique structure

It is characterized by its unique structure, which includes an anthraquinone core that is essential for its biological activity.

Medicinal chemistry potential

1,11a-didehydroanhydroanthramycin has shown promising potential in the field of medicinal chemistry, particularly in the treatment of cancer.

DNA targeting

Its ability to target specific DNA sequences and inhibit the growth of cancer cells makes it a valuable candidate for the development of novel anticancer drugs.

Antibacterial activity

1,11a-didehydroanhydroanthramycin has demonstrated potent antibacterial activity, making it a versatile compound with potential applications in both cancer therapy and infectious disease treatment.

Ongoing research and development

Its complex structure and multifaceted biological properties make it a subject of ongoing research and development in the pharmaceutical industry.

Anticancer drug development

Due to its DNA targeting and cancer cell growth inhibition properties, 1,11a-didehydroanhydroanthramycin is a promising candidate for the development of new anticancer drugs.

Versatility

The compound's potent antibacterial activity, in addition to its anticancer properties, makes it a versatile compound with potential applications in various areas of medicine.

Pharmaceutical industry interest

The unique structure and multifaceted biological properties of 1,11a-didehydroanhydroanthramycin have attracted the attention of the pharmaceutical industry, leading to ongoing research and development efforts.

Check Digit Verification of cas no

The CAS Registry Mumber 77165-77-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,1,6 and 5 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 77165-77:
(7*7)+(6*7)+(5*1)+(4*6)+(3*5)+(2*7)+(1*7)=156
156 % 10 = 6
So 77165-77-6 is a valid CAS Registry Number.
InChI:InChI=1/C16H13N3O3/c1-9-2-4-12-14(15(9)21)18-7-11-6-10(3-5-13(17)20)8-19(11)16(12)22/h2-8,21H,1H3,(H2,17,20)/b5-3+

77165-77-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-3-(4-hydroxy-3-methyl-11-oxopyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide

1.2 Other means of identification

Product number -
Other names C11a-C1-dehydro anthramycin N10-C11-imine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77165-77-6 SDS

77165-77-6Upstream product

77165-77-6Downstream Products

77165-77-6Relevant academic research and scientific papers

Observation of the reversibility of a covalent pyrrolobenzodiazepine (PBD) DNA adduct by HPLC/MS and CD spectroscopy

Rahman, Khondaker M.,James, Colin H.,Thurston, David E.

, p. 1632 - 1641 (2011)

Pyrrolobenzodiazepines (PBDs) are sequence-selective DNA minor-groove binding agents that covalently bond to guanine with a reported preference for Pu-G-Pu sequences (Pu = Purine). Using HPLC/MS and Circular Dichroism (CD) methodologies, we have established for the first time that the aminal bond formed between PBD molecules and DNA is reversible. Furthermore, we have shown that while the rate of aminal bond cleavage does not depend on the sequence preference of a PBD molecule for a particular binding site, the rate of re-formation of the PBD-DNA adduct does. We have also shown that the PBD anthramycin (2) appears to be an exception to this rule in that, during cleavage from the DNA, its C-ring aromatizes and it cannot then re-attach due to a loss of electrophilicity at the C11-position. Although the C-ring aromatization of anthramycin has been previously reported to occur in the absence of DNA and after treatment with trifluoroacetic acid (TFA), in this case no pH lowering was required, with the DNA itself appearing to catalyse the process. The Royal Society of Chemistry 2011.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 77165-77-6